Trade INDP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Indaptus Therapeutics, Inc. (INDP) is trading at US$2.26, down 12.74% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$171.88M. Over the past 52 weeks, INDP has traded between US$0.92 and US$5.96. On Syfe you can trade INDP with $0 commission and add it to your watchlist.
| Previous close | US$2.59 |
|---|---|
| Market cap | US$171.88M |
| 52-week range | US$0.92 – US$5.96 |
| Volume | 588.51K |
| Exchange | US |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Year: 2021
Top Premarket Decliners
Jun 5, 11:43 AM · MT Newswires
Indaptus Therapeutics, Inc. (INDP) stock is trading at US$2.26, -12.74% from the previous close of US$2.59.
The market cap for Indaptus Therapeutics, Inc. (INDP) stock is approximately US$171.88M.
The 52-week high for Indaptus Therapeutics, Inc. (INDP) stock is US$5.96.
The 52-week low for Indaptus Therapeutics, Inc. (INDP) stock is US$0.92.
Indaptus Therapeutics, Inc. (INDP) does not currently pay a dividend.
Stay on top of INDP
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
